Clinical Trial Update: Vitamin D3 for Aromatase Inhibitor Induced Arthralgias [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating vitamin D3 for arthralgia associated with aromatase inhibitor therapy in breast cancer patients; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Vitamin D3 (Cholecalciferol)

Snippet

Sponsor: Qamar Khan | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2018-02-09